TVTX
TRAVERE THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
TRAVERE THERAPEUTICS INC (TVTX) is held as common stock by 6 tracked hedge-fund managers, with a combined reported value of ~$140.25M; the largest are Renaissance Technologies, Steven Cohen, Izzy Englander. 2 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 2 new, 4 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Cooling
Common-stock holders62 also report options
Congress trades0
Price$61.57vs quarter-end+8.38%
Sectors0
This quarter's moves
Top holderNew2
Added0
Trimmed / sold4
Renaissance TechnologiesCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $5.86M— of portfolio103,2002026 Q2
Value $5.24M— of portfolio92,2002026 Q2
Value $329.5K— of portfolio5,8002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $5.86M | — | — |
| Ken GriffinPUT | $5.24M | — | — |
| Paul Tudor JonesPUT | $329.5K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.